Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Implied Disease Claims Provision Is Setback For Industry - Hutt

This article was originally published in The Tan Sheet

Executive Summary

Strict implementation and enforcement of the implied disease claims provision in FDA's structure/function claims final rule could mean "lost ground" for dietary supplement firms, eradicating gains resulting from the agency's "retreat" from the proposed "disease" definition, according to attorney Peter Barton Hutt.
Advertisement

Related Content

Vitamin E Health Claim Falls Short Of Significant Scientific Agreement - FDA
Hot Flashes, PMS Structure/Function Claims Allowed Under Final Rule

Topics

Advertisement
UsernamePublicRestriction

Register

PS090810

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel